¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20
±³À°ÀÏÀÚ : 2024-07-20
±³À°Àå¼Ò : ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥

ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : À¯ÁöÀÎ
¿¬¶ôó : 02-714-9072  

À̸ÞÀÏ : diabetes@kams.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í "Àü¹®ÀÇ, ÀüÀÓÀÇ, °³¿øÀÇ: »çÀü 50,000¿ø / ÇöÀå 70,000¿ø

Àü°øÀÇ, ¿¬±¸¿ø, Çлý: »çÀü 30,000¿ø / ÇöÀå 40,000¿ø"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 09:10~09:40 Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases ¼Û¹ÎÈ£(KAIST)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 09:40~10:00 Methods for Reducing Bias in Pharmacoepidemiological Studies Using Secondary Healthcare Data ±è´ëÁß(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:00~10:20 Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases Á¶¿µ¹Î(¼­¿ïÀÇ´ë)

Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:20~10:40 Q&A ( )

ÈÞ½Ä 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 10:40~11:00 Break ( )

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:00~11:20 Reflections on My Evolution as a Researcher À̽Âȯ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:20~11:40 Looking Back: The Early Days of My Research Journey ±è±Ô¸®(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 11:40~12:00 ³ªÀÇ ¿¬±¸ ºÐÅõ±â- Collaboration Wins All ¹®Áؼº(¿µ³²ÀÇ´ë)

Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 12:00~12:10 Q&A ( )

½Ä»ç 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 12:10~13:10 Lunch Break ( )

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:10~13:30 ³»ºÐºñ ¿¬±¸¿¡¼­ÀÇ ¿þ¾î·¯ºíµð¹ÙÀ̽ºÀÇ È°¿ë ±è°æÁø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:30~13:50 Current Status of Fully Closed-Loop System (Automated Insulin Delivery) ¹®¼±ÁØ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 13:50~14:10 ³»ºÐºñ ºÐ¾ßÀÇ Áø·á ¹× ¿¬±¸¿¡¼­ÀÇ chatGPTÀÇ È°¿ë ±è°æ¹Î(¿¬¼¼ÀÇ)

Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:10~14:20 Q&A ( )

ÈÞ½Ä 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:20~14:40 Break ( )

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 14:40~15:00 ´ë±Ô¸ð µ¥ÀÌÅÍÀÇ À¶ÇÕ ¹× AI¸¦ ÅëÇÑ In Silico LabÀÇ ±¸Ãà°ú Clinical Translation ÃÖÈ«À±(Æ÷Æ®·¡ÀÌ)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:00~15:20 AI¸¦ È°¿ëÇÑ ÀûÀÀÁõ È®Àå ±èÀ̶û(¿ÂÄÚÅ©·Î½º)

±³À°½Ã°£ 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:20~15:40 Clinical Proteomics and its Data Analysis for Drug Target Discovery and Diagnosis / Monitoring ±è°æ°ï(¾Æ»ê»ý¸í°úÇבּ¸¿ø)

Åä·Ð 07¿ù 20ÀÏ ¹é¹ü ±è±¸ ±â³ä°ü ÄÁº¥¼ÇȦ 15:40~15:50 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20
´ÙÀ½±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 37 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 25 2024-06-18
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 42 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 9 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 44 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 30 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 17 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 17 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 41 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 44 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 34 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 49 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 27 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 22 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 19 2024-06-18
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷